Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Curr Issues Mol Biol (2023) 45(6):454456
Effect of Baseline Body Mass Index on Glycemic Control and Weight Change With Exenatide Monotherapy in Chinese Drug-Nave Type 2 Diabetic Patients
Another says 2mL
Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells
This flat-rate pricing structure removes the financial barrier to dose escalation, allowing your clinician to optimize your treatment without cost concerns about reaching higher, more effective doses
US$ 25.10
US$ 26.30
US$ 20.13
US$ 25.74
US$ 24.12
US$ 26.15
US$ 22.29
